Henan University Shi Bingyang's team developed a new type of nanocapsules, breaking the blood-brain barrier and efficiently editing brain tumor cells
Sintilimab is included in the guidelines of the Chinese Society of Clinical Oncology (CSCO) for the first-line treatment of five major tumor types
Nature: Li Ming's team discovered a new type of T cells with stronger anti-cancer ability, bringing new hope for solid tumor immunotherapy
BMJ: Sintilimab combined with chemotherapy as first-line therapy significantly prolongs survival
J Immunother Cancer: Bempegaldesleukin combined with nivolumab in first-line treatment of advanced renal cell carcinoma
J Clin Oncol: The effect of tislelizumab in second-line treatment of advanced/metastatic esophageal squamous cell carcinoma
tislelizumab (TIS) + chemotherapy (chemo) versus chemotherapy alone in the first-line treatment of advanced
Lancet Oncol: Efficacy and safety of three first-line treatment regimens for metastatic clear cell renal cell carcinoma
A new type of cell death has been discovered!
A major breakthrough in acoustic genetics: the first use of sound to activate mammalian cells
Bristol-Myers Squibb's CAR-T therapy for second-line treatment of large B-cell lymphoma gets priority review
First-line treatment of non-small cell lung cancer mRNA vaccine/PD-1 antibody combination is about to enter the clinic
Cell sub-issue: Qiu Ju's team discovered the regulatory role of Setd2 on type 3 innate lymphocytes and intestinal immunity
Behind the scenes of type 1 diabetes: immune T cells that won't be exhausted "Nature" paper recommended
AS: The "high-precision compass" of the brain - a new type of head-direction cell in the somatosensory cortex
Cell Wang Fengbin et al. Analyze the evolution and assembly mechanism of lemon-type viruses
; domestic PD-1 refreshes chemoimmune combined with first-line treatment of advanced lung squamous cell carcinoma OS records tumor intelligence
Summary of studies on immunotherapy combined with platinum and etoposide regimens in the first-line
"The Lancet" Sub-Journal: Molecular typing can guide the selection of treatment options for renal